-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Victory Capital Management Inc. Sells 3,960 Shares of DA32 Life Science Tech Acquisition Corp. (NASDAQ:DALS)
Victory Capital Management Inc. Sells 3,960 Shares of DA32 Life Science Tech Acquisition Corp. (NASDAQ:DALS)
Victory Capital Management Inc. decreased its position in DA32 Life Science Tech Acquisition Corp. (NASDAQ:DALS – Get Rating) by 1.7% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 235,925 shares of the company's stock after selling 3,960 shares during the quarter. Victory Capital Management Inc. owned 0.92% of DA32 Life Science Tech Acquisition worth $2,300,000 at the end of the most recent reporting period.
Separately, Exos Asset Management LLC lifted its position in DA32 Life Science Tech Acquisition by 4.6% during the 1st quarter. Exos Asset Management LLC now owns 76,951 shares of the company's stock worth $748,000 after buying an additional 3,402 shares in the last quarter. Hedge funds and other institutional investors own 60.86% of the company's stock.
Get DA32 Life Science Tech Acquisition alerts:DA32 Life Science Tech Acquisition Stock Performance
Shares of NASDAQ DALS opened at $9.72 on Friday. The firm's 50-day simple moving average is $9.70 and its 200 day simple moving average is $9.69. DA32 Life Science Tech Acquisition Corp. has a 12-month low of $9.58 and a 12-month high of $10.26.
DA32 Life Science Tech Acquisition Company Profile
(Get Rating)DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science infrastructure sectors.
Read More
- Get a free copy of the StockNews.com research report on DA32 Life Science Tech Acquisition (DALS)
- Look at Honeywell for a Steady and Diversified Stock
- Why Invest in High-Yield Dividend Stocks?
- Disney (NYSE: DIS) Shares Just Gave Investors A Massive Signal
- Find and Profitably Trade Stocks at 52-Week Lows
- Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
Want to see what other hedge funds are holding DALS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DA32 Life Science Tech Acquisition Corp. (NASDAQ:DALS – Get Rating).
Receive News & Ratings for DA32 Life Science Tech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DA32 Life Science Tech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
Victory Capital Management Inc. decreased its position in DA32 Life Science Tech Acquisition Corp. (NASDAQ:DALS – Get Rating) by 1.7% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 235,925 shares of the company's stock after selling 3,960 shares during the quarter. Victory Capital Management Inc. owned 0.92% of DA32 Life Science Tech Acquisition worth $2,300,000 at the end of the most recent reporting period.
據勝利資本管理公司在最近提交給美國證券交易委員會的文件中稱，該公司今年第一季度將其在DA32生命科學技術收購公司(DA32 Life Science Tech Acquisition Corp.)的持倉減少了1.7%。該基金在本季度出售了3960股後，持有235,925股該公司股票。在最近的報告期結束時，勝利資本管理公司擁有DA32生命科學技術公司收購的0.92%的股份，價值230萬美元。
Separately, Exos Asset Management LLC lifted its position in DA32 Life Science Tech Acquisition by 4.6% during the 1st quarter. Exos Asset Management LLC now owns 76,951 shares of the company's stock worth $748,000 after buying an additional 3,402 shares in the last quarter. Hedge funds and other institutional investors own 60.86% of the company's stock.
另外，Exos Asset Management LLC在第一季度將其在DA32生命科學技術公司收購中的頭寸提高了4.6%。EXOS Asset Management LLC現在持有76,951股該公司股票，價值748,000美元，上個季度又購買了3,402股。對衝基金和其他機構投資者持有該公司60.86%的股票。
DA32 Life Science Tech Acquisition Stock Performance
DA32生命科學技術收購股票表現
Shares of NASDAQ DALS opened at $9.72 on Friday. The firm's 50-day simple moving average is $9.70 and its 200 day simple moving average is $9.69. DA32 Life Science Tech Acquisition Corp. has a 12-month low of $9.58 and a 12-month high of $10.26.
上週五，納斯達克大眾點評的股價開盤報9.72美元。該公司的50日簡單移動均線切入位為9.70美元，200日簡單移動均線切入位為9.69美元。DA32生命科學技術收購公司的股價跌至9.58美元的12個月低點和10.26美元的12個月高位。
DA32 Life Science Tech Acquisition Company Profile
DA32生命科學技術收購公司簡介
DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science infrastructure sectors.
DA32生命科學技術收購公司沒有重大業務。它側重於與一個或多個企業進行合併、資本換股、資產收購、股票購買、重組或相關業務合併。該公司打算確定生物技術和生命科學基礎設施領域的業務合併目標。
Read More
閲讀更多內容
- Get a free copy of the StockNews.com research report on DA32 Life Science Tech Acquisition (DALS)
- Look at Honeywell for a Steady and Diversified Stock
- Why Invest in High-Yield Dividend Stocks?
- Disney (NYSE: DIS) Shares Just Gave Investors A Massive Signal
- Find and Profitably Trade Stocks at 52-Week Lows
- Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
- 免費獲取StockNews.com關於DA32生命科學技術收購(DALS)的研究報告
- 霍尼韋爾看好穩定和多元化的股票
- 為什麼要投資高收益股利股票？
- 迪士尼(NYSE：DIS)的股票剛剛給了投資者一個巨大的信號
- 找到並獲利於52周低點的股票交易
- 清潔能源法案通過後，太陽能股大放異彩
Want to see what other hedge funds are holding DALS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DA32 Life Science Tech Acquisition Corp. (NASDAQ:DALS – Get Rating).
想看看其他對衝基金持有哪些DAL嗎？訪問HoldingsChannel.com獲取DA32生命科學技術收購公司(納斯達克代碼：DALS-Get Rating)的最新13F備案文件和內幕交易信息。
Receive News & Ratings for DA32 Life Science Tech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DA32 Life Science Tech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
獲得DA32生命科學技術收購日報的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對DA32生命科學技術收購和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧